Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

70.38 +0.84 (+1.21%)
Official Closing Price Updated: 4:10 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,734,593
Open 69.65
Bid (Size) 69.36 (1)
Ask (Size) 70.90 (1)
Prev. Close 69.54
Today's Range 69.16 - 70.88
52wk Range 58.93 - 95.73
Shares Outstanding 589,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-6.87%
-6.87%
1 Month
+0.47%
+0.47%
3 Month
+0.41%
+0.41%
6 Month
-21.98%
-21.98%
1 Year
+5.11%
+5.11%

More News

Read More
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
Via TheNewswire.com
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
Via NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EW INVESTORS: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action
From Robbins LLP
Via GlobeNewswire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Edwards Lifesciences Corporation to Contact Us to Have Their Losses Evaluated Today
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
From Edwards Lifesciences Corporation
Via Business Wire
Why is Boston Scientific Stock Trading Lower On Wednesday?
Via Benzinga
TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
From Edwards Lifesciences Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TD, Edwards, and UPS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
From Edwards Lifesciences Corporation
Via Business Wire
EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Edwards Lifesciences Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.